Urolithin A

Urolithin A is a postbiotic metabolite derived from ellagitannin-rich foods that activates mitophagy, the cellular process of removing damaged mitochondria. This compound enhances mitochondrial function, supports muscle health, and reduces age-related cellular decline.

Origin & History

Urolithin A is a metabolite produced by the gut microbiota from ellagic acid, found in pomegranates and some berries. It is extracted through fermentation processes using specific bacterial strains.

Historical & Cultural Context

Urolithin A's discovery is recent, linked to the study of pomegranate's health benefits. Traditionally, pomegranates have been valued for their antioxidant properties.

Health Benefits

- Enhances mitochondrial function and energy production, increasing cellular ATP levels by 30%. This combats fatigue and boosts vitality. - Supports muscle health by reducing age-related muscle decline, preserving muscle mass. This enhances physical performance. - Reduces inflammation by modulating immune responses, lowering inflammatory markers. This promotes overall health and longevity. - Improves cognitive function by enhancing brain mitochondrial efficiency, supporting memory and focus. This boosts mental clarity. - Supports cardiovascular health by improving endothelial function, reducing heart disease risk. This enhances circulatory health. - Promotes skin health by reducing oxidative stress, delaying signs of aging. This maintains youthful skin appearance. - Enhances metabolic health by improving lipid metabolism, aiding in weight management. This supports a healthy body composition.

How It Works

Urolithin A activates mitophagy by inducing the PINK1/Parkin pathway, promoting the selective removal of damaged mitochondria. It upregulates PGC-1α expression, enhancing mitochondrial biogenesis and increasing cellular ATP production. The compound also modulates NF-κB signaling to reduce inflammatory cytokine production.

Scientific Research

Numerous RCTs have demonstrated Urolithin A's role in improving mitochondrial health and muscle function. In vitro studies support its anti-inflammatory effects. Meta-analyses are ongoing to further validate these findings.

Clinical Summary

Human clinical trials with 500-1000mg daily doses show Urolithin A increases cellular ATP by up to 30% and improves muscle endurance markers. A 4-month randomized controlled trial in 60 elderly adults demonstrated significant improvements in mitochondrial gene expression and muscle function. However, most evidence comes from small-scale studies, and larger long-term trials are needed to confirm safety and efficacy across diverse populations.

Nutritional Profile

- Not a direct dietary component but a metabolite. - Derived from ellagitannins found in fruits like pomegranates. - Requires a healthy gut microbiome for production.

Preparation & Dosage

Typical dosage ranges from 250 mg to 500 mg per day. Available in capsule or powder form. Consult a healthcare provider before use.

Synergy & Pairings

Ellagic Acid, Pomegranate Extract, Resveratrol

Safety & Interactions

Urolithin A appears well-tolerated in clinical studies with minimal reported side effects at doses up to 1000mg daily. Some individuals may experience mild gastrointestinal upset during initial supplementation. No significant drug interactions have been reported, but individuals taking medications for diabetes should monitor blood glucose levels. Safety during pregnancy and breastfeeding has not been established.